Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
2(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
53%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(9)
Other(4)

Detailed Status

Completed9
unknown4
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (11.1%)
N/A8 (88.9%)

Trials by Status

active_not_recruiting17%
recruiting17%
unknown427%
completed960%

Recent Activity

Clinical Trials (15)

Drug Details

Intervention Type
OTHER
Total Trials
15